The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Oncolytics Biotech Inc(NASDAQ:ONCY) 
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. Th...
Oncolytics Biotech Days Payable Outstanding ttm (DPO)
Oncolytics Biotech Op Cashflow Per Share ttm
Oncolytics Biotech Free Cashflow Per Share ttm
Oncolytics Biotech Cash Per Share ttm
Oncolytics Biotech (GAAP) P/E ratio ttm
Oncolytics Biotech P/B ratio ttm
No extra charts and metrics for this ticker.